D.E. Shaw & Co’s ChemoCentryx CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-20,000
Closed -$1.03M – 5555
2022
Q3
$1.03M Hold
20,000
– – ﹤0.01% 3576
2022
Q2
$496K Hold
20,000
– – ﹤0.01% 4093
2022
Q1
$501K Hold
20,000
– – ﹤0.01% 4371
2021
Q4
$728K Hold
20,000
– – ﹤0.01% 4160
2021
Q3
$342K Buy
+20,000
New +$312K ﹤0.01% 4288

Other funds holding CCXI

D.E. Shaw & Co's CCXI Position: Q4 2022 in Review

D.E. Shaw & Co sold out of ChemoCentryx (CCXI) in Q4 2022, closing a stake of 46,619 shares — an estimated $2.41M sold.

D.E. Shaw & Co first reported a position in CCXI in Q2 2013 and held it in 34 quarters. The position peaked at $43.2M in Q4 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • D.E. Shaw & Co reported no remaining ChemoCentryx position as of Q4 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 46,619 ChemoCentryx shares in Q4 2022, an estimated $2.41M.
  • D.E. Shaw & Co first reported a position in ChemoCentryx in Q2 2013 and held it in 34 quarters.
  • D.E. Shaw & Co's ChemoCentryx position peaked at $43.2M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.